salmeterol xinafoate has been researched along with Multiple Sclerosis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ascencio, M; Asche, CV; Raimondi, T; Rainville, EC; Ren, J; Valenzuela, RM | 1 |
Axelrod, S; Bielory, L | 1 |
2 other study(ies) available for salmeterol xinafoate and Multiple Sclerosis
Article | Year |
---|---|
Association Between Exposure of Ipratropium and Salmeterol and Diagnosis of Multiple Sclerosis: A Matched Case-control Study.
Topics: Adolescent; Adult; Aged; Bronchodilator Agents; Case-Control Studies; Female; Humans; Ipratropium; Male; Middle Aged; Multiple Sclerosis; Salmeterol Xinafoate; Young Adult | 2019 |
Beta2-agonists and paresthesias in multiple sclerosis.
Topics: Adrenergic beta-Agonists; Albuterol; Amantadine; Analgesics, Non-Narcotic; Androstadienes; Aromatase Inhibitors; Asthma; Bronchodilator Agents; Donepezil; Drug Therapy, Combination; Female; Fluticasone; Food Hypersensitivity; Humans; Indans; Interferons; Latex Hypersensitivity; Letrozole; Mandelic Acids; Middle Aged; Multiple Sclerosis; Nebulizers and Vaporizers; Nitriles; Nootropic Agents; Parasympatholytics; Paresthesia; Piperidines; Respiratory Function Tests; Salmeterol Xinafoate; Thyroxine; Triazoles | 2007 |